| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Tandem Diabetes Care, Inc.'s insiders have reduced their positions by a net 1,700 shares worth roughly $33K. In the past 30 days, 0 insiders bought and 1 sold.
The insider who sold still holds shares after the sale.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 160.3K | $2.83M | - | |
| VP | 52.8K | $931.7K | - | |
| CFO | 52.0K | $918.5K | - | |
| VP | 40.3K | $711.6K | - | |
| VP | 32.1K | $567.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2018 | Howard E Greene Jr. | Director | Sell | 11,787 | $36.53 | $430,579.11 | -19.1% | |
| Nov 5, 2018 | Dick Allen69 | Director | Sell | 15,222 | $38.02 | $578,675.98 | -22.6% | |
| Nov 5, 2018 | Richard P. Valencia | Director | Buy | 1,300 | $37.75 | $49,075.00 | +74.1% | |
| Aug 3, 2018 | Richard P. Valencia | Director | Buy | 1,754 | $28.50 | $49,989.00 | New | |
| Mar 6, 2018 | Dick Allen69 | Director | Buy | 25,539 | $3.88 | $99,217.08 | -721.8% | |
| Feb 9, 2018 | Kim D Blickenstaff61 | President & CEO | Buy | 750,000 | $2.00 | $1,500,000.00 | +154.2% | |
| Feb 9, 2018 | Douglas A Roeder70 | Director | Buy | 1,000,000 | $2.00 | $2,000,000.00 | -101.3% | |
| Feb 9, 2018 | Dick Allen69 | Director | Buy | 60,000 | $2.00 | $120,000.00 | -130.1% | |
| Feb 9, 2018 | Howard E Greene Jr. | Director | Buy | 50,000 | $2.00 | $100,000.00 | +424.2% | |
| Feb 9, 2018 | Christopher J Twomey59 | Director | Buy | 75,000 | $2.00 | $150,000.00 | -155.5% |